News
Researchers at King’s College London are starting a world-first clinical trial to test if a probiotic drink could help with motor and non-motor symptoms of Parkinson's.
New report on services in Scotland.
A clinical trial has produced further evidence that there is no benefit of delaying levodopa therapy.
We’re investing a further £1.5million to advance pioneering drug discovery work to develop new molecules that can both improve symptoms and slow progression.
European study suggests that smoking has a protective role to reduce the risk of developing Parkinson's.
A US study has found that people with Attention-Deficit Hyperactivity Disorder (ADHD) may have an increased risk of developing Parkinson's.
In August 2018, Kyle Alexander was appointed by co-option to the Board of Trustees, bringing a Northern Ireland presence to the board.
Researchers in Israel have made positive steps towards a simple diagnostic test for Parkinson's.
The government have announced a relaxation of the laws governing access to cannabis-based medicines. This will give doctors the ability to prescribe them.
Researchers in America have developed an experimental drug, similar to compounds used to treat diabetes, that slows the progression of Parkinson's in a mouse model of the condition.